Topic: cardiovascular disease
Understanding aging in cells beyond the brain could lead to new therapies for diabetes and more, Salk scientists say.
The partners will apply Arvinas’ targeted protein degrader technology to cardiovascular, oncological and gynecological targets selected by Bayer.
Mount Sinai researchers showed that in male mouse models of heart attack, Cdx2 placental cells regenerated damaged tissue.
The web-based solution detects and classifies the sounds of potentially dangerous heart murmurs using a digital stethoscope.
Researchers in Israel have printed a three-dimensional human heart using bioinks developed from a patient’s own cells.
IRhythm’s ECG patch was able to improve atrial fibrillation diagnoses and lower numbers of ER visits by shifting patients to outpatient settings.
Canvassing more than 400,000 people in 8 months, Apple has finished an investigation of its smartwatch’s ability to detect irregular heart rhythms.
British researchers discovered that blocking the protein MAP4K4, which is activated by stress signals, can reduce muscle damage from a heart attack.
The decision sets Novartis up to test the RNA-targeting drug in a phase 3 cardiovascular outcomes trial.
FineHeart’s device is a miniaturized, fully implantable pump that is synchronized to the beat of the heart—combining the functions of a pacemaker and an LVAD in a single unit—with the added advantages of being safer and easier to implant.